Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce S Plested

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Methods in Molecular Medicine|October 11, 2002
Opsonophagocytosis assay using flow-cytometryJoyce S Plested, Philip A Coull
Clinical and Vaccine Immunology : CVI|April 3, 2009
Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activityJoyce S Plested, Jo Anne Welsch, Dan M Granoff
Methods in Molecular Medicine|October 11, 2002
ELISAJoyce S Plested, Philip A Coull, Margaret Anne J Gidney
Plos Medicine|October 1, 2021
Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trialNeil Formica, Raburn Mallory, Gary Albert, et al.
European Journal of Biochemistry|April 16, 2003
Identification of a novel inner-core oligosaccharide structure in Neisseria meningitidis lipopolysaccharideAndrew D Cox, J Claire Wright, Margaret A J Gidney, et al.
Journal of Medical Virology|October 21, 2025
Detection of Anti-SARS-CoV-2 Mucosal Immunoglobulin A in Clinical Saliva Samples After a Dose of Novavax COVID-19 VaccineMingzhu Zhu, Edmond Massuda, Urvashi Patel, et al.
Journal of Virological Methods|April 22, 2024
Validation of a severe acute respiratory syndrome coronavirus 2 microneutralization assay for evaluation of vaccine immunogenicityStephanie Hamilton, Mingzhu Zhu, Shane Cloney-Clark, et al.
Microorganisms|February 25, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity EvaluationJoyce S Plested, Mingzhu Zhu, Shane Cloney-Clark, et al.
The Journal of Infection|October 17, 2024
Mechanisms and implications of IgG4 responses to SARS-CoV-2 and other repeatedly administered vaccinesAnthony M Marchese, Louis Fries, Hadi Beyhaghi, et al.
Microorganisms|May 27, 2026
Validation of a Mucosal IgA Assay for SARS-CoV-2Mingzhu Zhu, Edmond Massuda, Shane Cloney-Clark, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Methods in Molecular Medicine|October 11, 2002
Opsonophagocytosis assay using flow-cytometryJoyce S Plested, Philip A Coull
Clinical and Vaccine Immunology : CVI|April 3, 2009
Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activityJoyce S Plested, Jo Anne Welsch, Dan M Granoff
Methods in Molecular Medicine|October 11, 2002
ELISAJoyce S Plested, Philip A Coull, Margaret Anne J Gidney
Plos Medicine|October 1, 2021
Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trialNeil Formica, Raburn Mallory, Gary Albert, et al.
European Journal of Biochemistry|April 16, 2003
Identification of a novel inner-core oligosaccharide structure in Neisseria meningitidis lipopolysaccharideAndrew D Cox, J Claire Wright, Margaret A J Gidney, et al.
Journal of Medical Virology|October 21, 2025
Detection of Anti-SARS-CoV-2 Mucosal Immunoglobulin A in Clinical Saliva Samples After a Dose of Novavax COVID-19 VaccineMingzhu Zhu, Edmond Massuda, Urvashi Patel, et al.
Journal of Virological Methods|April 22, 2024
Validation of a severe acute respiratory syndrome coronavirus 2 microneutralization assay for evaluation of vaccine immunogenicityStephanie Hamilton, Mingzhu Zhu, Shane Cloney-Clark, et al.
Microorganisms|February 25, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity EvaluationJoyce S Plested, Mingzhu Zhu, Shane Cloney-Clark, et al.
The Journal of Infection|October 17, 2024
Mechanisms and implications of IgG4 responses to SARS-CoV-2 and other repeatedly administered vaccinesAnthony M Marchese, Louis Fries, Hadi Beyhaghi, et al.
Microorganisms|May 27, 2026
Validation of a Mucosal IgA Assay for SARS-CoV-2Mingzhu Zhu, Edmond Massuda, Shane Cloney-Clark, et al.
Pageof 5